Paasa Logo
Ironwood Pharmaceuticals, Inc. logo
IRWDNASDAQMarket closedOpens 9:30am ET

Ironwood Pharmaceuticals, Inc.

$4.13Last updated
-$0.06 (1.43%)Past day
Timezone

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) is trading at $4.13, about ₹396 at today's USD/INR rate, as of 25 Sep 2026, 4:00 PM ET, down 1.43% today. Indian residents can buy Ironwood Pharmaceuticals from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$4.24
Previous close:$4.19
Volume:1.32M

Today's low

$4.10

Today's high

$4.25

52 week low

$1.26

52 week high

$5.78

IRWD opened at $4.24, closed previously at $4.19, and has traded between $1.26 and $5.78 over the past 52 weeks.

About

Ironwood Pharmaceuticals, Inc. operates as a healthcare enterprise primarily dedicated to discovering, developing, and commercializing therapeutic solutions for gastrointestinal (GI) conditions. Its flagship commercial product is linaclotide, a guanylate cyclase type-C (GC-C) agonist. This medication is prescribed for adult patients managing irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC), sold as LINZESS in the United States and Mexico, and under the CONSTELLA brand throughout Canada and the European Union. Beyond its marketed offerings, Ironwood's development pipeline includes IW-3300, another GC-C agonist targeting various visceral pain conditions, such as interstitial cystitis/bladder pain syndrome and endometriosis. Additionally, the company is advancing CNP-104, an immune nanoparticle being investigated for biliary cholangitis. Ironwood maintains key strategic alliances with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. to support the ongoing development and market introduction of linaclotide. Established in 1998, the Boston, Massachusetts-based firm initially operated as Microbia, Inc. before officially rebranding to Ironwood Pharmaceuticals, Inc. in April 2008.

Country
US
CEO
Thomas A. McCourt
Exchange listed on
NASDAQ
Industry
Drug Manufacturers - Specialty & Generic
Base currency
USD
Full Time Employees
100
Sector
Healthcare
IPO date
03/02/2010

Key statistics

Avg. volume

2.24M

Market cap

$679.85M

P/E Ratio

5.19

Price-to-sales ratio

1.75

Enterprise value

$997.59M

Free cash flow yield

27.29%

Debt-to-equity ratio

-2.45

Return on equity

-57.40%

ROIC

57.85%

Beta

0.21

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$296.15M

Earnings per share

$0.15

Free cash flow

$127.01M

Net profit margin

33.36%

Gross margin

99.76%

EBITDA

$104.65M

Revenue growth

-15.72%

Similar securities

This is not an investment recommendation

How to buy Ironwood Pharmaceuticals from India

Indian residents can buy Ironwood Pharmaceuticals shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Ironwood Pharmaceuticals and place an order

    Find Ironwood Pharmaceuticals by name or by its ticker, IRWD, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Ironwood Pharmaceuticals trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Ironwood Pharmaceuticals position in USD and INR. Ironwood Pharmaceuticals pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Ironwood Pharmaceuticals from India

Trading and taxes when buying Ironwood Pharmaceuticals from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneIronwood Pharmaceuticals does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Ironwood Pharmaceuticals stock?

Yes. Ironwood Pharmaceuticals (IRWD) has been listed on NASDAQ since 2010, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Ironwood Pharmaceuticals share cost in rupees?

One Ironwood Pharmaceuticals share is $4.13 — about ₹396 at a USD/INR rate of 95.92 on 25 Sep 2026. Both the Ironwood Pharmaceuticals price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Ironwood Pharmaceuticals from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Ironwood Pharmaceuticals?

Yes. One Ironwood Pharmaceuticals share is $4.13, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Ironwood Pharmaceuticals.

How are gains on Ironwood Pharmaceuticals shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Ironwood Pharmaceuticals price. Paasa issues a capital-gains statement for your return.

Does Ironwood Pharmaceuticals pay a dividend?

No. Ironwood Pharmaceuticals does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Ironwood Pharmaceuticals from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is there estate or inheritance tax on Ironwood Pharmaceuticals shares held from India?

US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.

Do I have to declare Ironwood Pharmaceuticals shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Ironwood Pharmaceuticals holding, its cost and its closing value.

How do I sell Ironwood Pharmaceuticals and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.